Drug maker Johnson & Johnson will pay $7.8 million to settle a Risperdal lawsuit alleging that its subsidiary Janssen Pharmaceuticals illegally promoted the drug in Arkansas. Lawyers asserted that Janssen committed Medicaid fraud and violated Arkansas state laws by failing to properly warn doctors of potential Risperdal side effects.
Risperdal is commonly used to treat mental disorders such as schizophrenia and bipolar disorder, but has also been marketed to treat the symptoms of ADHD and other disorders in youth. The drug has also been linked to an increased risk of gynecomastia, or breast tissue growth in boys and male adolescents.
Several patients have filed Risperdal breast growth lawsuits against the company after being given the drug in adolescence and developing breasts. A 20-year old Alabama man began receiving Risperdal at age 12, eventually developing size 46DD breasts. He was awarded more than $1 million in February 2015.
Filing a Risperdal Breast Growth Lawsuit
If you or a loved one experienced breast development after using Risperdal, you may be eligible to file a lawsuit. Contact the lawyers at Hissey Kientz, LLP for a free case evaluation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page.